Skip to content

Inspection prep notes · Sterility and contamination control

Cross-contamination and cleaning validation

Also called: cross-contamination, cleaning validation

FDA looks less at whether a cleaning procedure exists than at whether it has been shown to actually remove residue from equipment. The findings below are quoted from warning letters and FDA 483s.

What inspectors cited

1Cleaning of shared equipment was not validated

Your firm also failed to validate your cleaning processes for non-dedicated equipment used to manufacture your OTC drug products.

FDA Warning Letter · Woodbine Products Company Inc. · 2026-08-04 · View document

You have not completed equipment cleaning validation studies to validate equipment cleaning SOP #10, Cleaning and Sanitization Procedure Packaging Room and Equipment, effective date 02/01/2024 which is used for the cleaning of shared equipment used in the packaging of the drug products [redacted] and [redacted] as well as several [redacted] products.

FDA 483 · Paxeuticals LLC · 2026-10-27 · View document

2Residue was left on equipment and in the work area

For example, our investigator observed stagnant (b)(4) product residue inside the tubing on the filling line with residue accumulating in crevices and on surfaces that come into direct contact with the drug product.

FDA Warning Letter · Lico Industries, LLC., d.b.a. American Towelette Company · 2026-08-11

On 01/06/2026 dispensing bay was observed with remains of apparent white powder residue on the walls, floor, and on the dust snorkel which sits above the product being weighed out.

FDA 483 · GOJO Industries LLC · 2026-10-23 · View document

3Dirty and clean hold times for equipment were not supported by studies

Yet, you have not performed a Clean Hold Time (CHT) and Dirty Hold Time Study (DHT) after (as worst-case molecule in 2022) and (as worst-case molecule in 2023-2024) as required per SOP # UNIT PR/SOP/0017-02 “Cleaned and Dirty Equipment Hold Time, effective date 03/08/2026” as introduction of new product at the site.

FDA 483 · Shilpa Medicare Limited · 2026-10-22 · View document

You established a clean hold time (CHT) of [redacted] and a dirty hold time (DHT) o [redacted] for equipment without performing adequate studies to support the CHT and DHT.

FDA 483 · Blossom Pharmaceuticals · 2026-10-22 · View document

4Beta-lactam products were not separated from other products

You failed to ensure complete and comprehensive separation of cephalosporin and (b)(4) drug products in this shared facility.

FDA Warning Letter · Baxter International Inc. · 2026-10-20 · View document

Specifically, Your firm failed to have separate dedicated facilities to prevent cross contamination of non-penicillin beta-lactam drug products that are repackaged in the same facility as non-beta-lactam drug products.

FDA 483 · Pine Pharmaceuticals, LLC · 2025-02-12 · View document

5Cleaning records did not show what was done or when it was verified

In addition, you failed to adequately document the type of cleaning performed or the specific cleaning agent used to clean your equipment that is shared to manufacture both your OTC drug products and cosmetics.

FDA Warning Letter · Stream2Sea, LLC · 2026-09-29 · View document

Multiple instances were observed on your cleaning records where the QA verifier initialed and dated the cleaning records days after the cleaning operations were performed.

FDA 483 · LeeSar Inc · 2026-11-05 · View document

Questions to check against your procedures

  1. Has a cleaning validation study been completed for each piece of shared equipment used for more than one product?
  2. Are the inside of tubing, crevices and product-contact surfaces free of residue after equipment has been cleaned?
  3. Are the walls, floor and dust extraction arm of the dispensing area free of powder residue?
  4. Are the clean hold time and dirty hold time supported by studies, and were the studies repeated when a new product was introduced?
  5. Are beta-lactam products handled in dedicated facilities separate from other products?
  6. Do cleaning records show the type of cleaning and the cleaning agent used, and does the verifier sign and date them at the time of the work?

Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-15.

Weekly Newsletter

New GMP inspection findings, every Monday

Every Monday we email the week's new inspection records from the FDA, EMA, Health Canada and MFDS, with a short summary of the week's regulatory news. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.